News
Macquarie Value Fund Institutional Class shares trailed its benchmark, the Russell 1000® Value Index. Click here to read the ...
Corcept's main revenue driver, Korlym, helps treat hyperglycemia in adults with Cushing's Syndrome. Read why I rate CORT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback